Pause-dependent polymorphic ventricular tachycardia during long-term treatment with dofetilide
Open Access
- 5 March 2001
- journal article
- clinical trial
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 37 (4), 1100-1105
- https://doi.org/10.1016/s0735-1097(01)01106-8
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Dofetilide for the treatment of atrial fibrillation in patients with congestive heart failurePublished by Oxford University Press (OUP) ,2000
- Dofetilide in Patients with Congestive Heart Failure and Left Ventricular DysfunctionNew England Journal of Medicine, 1999
- Electrophysiologic profile and efficacy of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with sustained monomorphic ventricular tachycardiaThe American Journal of Cardiology, 1995
- Sudden cardiac death and polymorphous ventricular tachycardia in pationts with normal QT intervals and normal systolic cardiac functionThe American Journal of Cardiology, 1995
- SotalolNew England Journal of Medicine, 1994
- Spiral Wave Activity:Journal of Cardiovascular Electrophysiology, 1993
- Effects of the class III antiarrhythmic drug dofetilide on ventricular monophasic action potential duration and QT interval dispersion in stable angina pectorisThe American Journal of Cardiology, 1992
- Rate-Dependent Class III Antiarrhythmic Action, Negative Chronotropy, and Positive Inotropy of a Novel Ik Blocking Drug, UK-68,798Journal of Cardiovascular Pharmacology, 1990
- Ambulatory sudden cardiac death: Mechanisms of production of fatal arrhythmia on the basis of data from 157 casesAmerican Heart Journal, 1989
- Incidence and clinical features of the quinidine-associated long QT syndrome: Implications for patient careAmerican Heart Journal, 1986